- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 2nd, 2007
Domestic anti-cancer drug major Dabur Pharma is finalising plans to enter Japan and China. The company has started the groundwork of filing drug applications and is scouting for potential pharma acquisitions in both the countries.
Dabur Pharma also plans to expand the range of products developed on its nanotechnology drug delivery system, christened ‘Nanoxel'. At the moment, it sells the popular anti-cancer drug ‘Paclitaxel' on this platform. "We also want to export this portfolio of drugs in US, Europe and South-east Asian markets," said Mr Vij.
|Related News Press|
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015
Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015
Scientists design a QKD-based quantum private query with no failure November 25th, 2015
Keysight Technologies Begins Trading as Independent Company November 3rd, 2014